Skin rash and splinter hemorrhages from ganciclovir

Sandra Lorenzi, A. D'Antuono, M. Iorizzo, Antonella Tosti

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

Ganciclovir is a nucleotide-analogue similar to acyclovir, which has an in vitro activity against herpes simplex type 1, herpes simplex type 2 and varicella zoster virus. Numerous studies suggest that ganciclovir has clinical efficacy against cytomegalovirus disease, as well as an in vivo antiviral effect, and that this agent reduces morbidity of serious cytomegalovirus infections in immuno-compromised patients. Generalised cutaneous rash associated with ganciclovir therapy has rarely been reported in literature.

Original languageEnglish
Pages (from-to)177-178
Number of pages2
JournalJournal of Dermatological Treatment
Volume14
Issue number3
DOIs
StatePublished - Sep 1 2003
Externally publishedYes

    Fingerprint

Keywords

  • Ganciclovir
  • HIV
  • Skin rash
  • Splinter hemorrhages

ASJC Scopus subject areas

  • Dermatology

Cite this